SCHEDULE TO REPORT BENEFICIAL OWNERSHIP OF 5% OR MORE

Company

Bicara Therapeutics Inc.

Filed

September 18, 2024

Accession Number

0001999371-24-012103

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →